electroCore Inc ECOR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
Trading Information
- Previous Close Price
- $6.64
- Day Range
- $6.54–7.05
- 52-Week Range
- $4.16–10.50
- Bid/Ask
- $6.40 / $7.83
- Shares Outstanding
- 8.30M
- Market Cap
- $54.71M
- Volume/Avg
- 30,607 / 109,444
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.96
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
electroCore Inc is a bioelectronic technology company whose mission is to improve health and quality of life through non-invasive bioelectronic technologies. Its two commercial products are gammaCore non-invasive vagus nerve stimulation, or nVNS, and Quell Fibromyalgia, or Quell. It also sells Truvaga and TAC-STIM products, which are handheld, personal-use consumer products developed to promote general wellness and human performance. It operates in one segment: Bioelectronic Innovations. Geographically, it operates in the United States, the United Kingdom, Japan, and Other.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 83
- Website
- https://www.electrocore.com
Valuation
|
Metric
|
ECOR
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 1.96 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
ECOR
|
|---|---|
Quick Ratio | 0.79 |
Current Ratio | 1.02 |
Interest Coverage | −25.85 |
Quick Ratio
ECOR
Profitability
|
Metric
|
ECOR
|
|---|---|
Return on Assets (Normalized) | −75.43% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | −176.88% |
Return on Assets
ECOR
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|<&NWRzx | LOCK|&CSNc | $164B | |||
| Stryker Corp
SYK
| LOCK|?&!%nZ% | LOCK|pJL | $126B | |||
| Medtronic PLC
MDT
| LOCK|FWpw#^# | LOCK|$>X< | $107B | |||
| Boston Scientific Corp
BSX
| LOCK|r$%!c^W | LOCK|zqcng | $67B | |||
| Edwards Lifesciences Corp
EW
| LOCK|@ZJ%Q&Y | LOCK|?@RM | $53B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|<W!CVv | LOCK|yf | $29B | |||
| DexCom Inc
DXCM
| LOCK|DT@G%%g% | LOCK|g!VPl | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|!^ | LOCK|Gj | $27B | |||
| Steris PLC
STE
| LOCK|z<$>CSx | LOCK|q%F< | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|!rhLRmk | LOCK|S?> | $18B |
United States